Retham Technologies

Seed
rethamtechnologies.com Biotech & Healthcare Wauwatosa, United States
Total Funding $1.5M
Latest Round $1.5M Seed
Last Announced Sep 15, 2026
Investors 5 Backers
Decision Makers 3 Verified

About Retham Technologies

Retham Technologies is a biotech company that provides a diagnosis of heparin induced thrombocytopenia by enabling rapid HIT testing.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Wauwatosa, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website rethamtechnologies.com
Domain Registered Date May 19, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $1,500,000 · Seed

    linkedin.com

  2. Milestone

    Website domain registered

    rethamtechnologies.com

Investors & Backers

5
Golden Angels Investors
Milwaukee Venture Partners
National Institutes of Health
SBIR Advance
Talents Fund

Funding History

1 Round
Seed · Sep 15, 2026
$1,500,000 linkedin.com

Founders & Leadership

1

Anand Padmanabhan

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts